Cargando…
Spore powder of Ganoderma lucidum for Alzheimer's disease: A protocol for systematic review
BACKGROUND: Previous studies have reported that spore powder of Ganoderma lucidum (SPGL) may be effective for the treatment of Alzheimer's disease (AD). However, its efficacy is still inconclusive. Thus, this systematic review will aim to assess its efficacy and safety for AD. METHODS: We will...
Autores principales: | Qin, Li-Hong, Wang, Chen, Qin, Li-Wei, Liang, Yan-Feng, Wang, Guo-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380698/ https://www.ncbi.nlm.nih.gov/pubmed/30702632 http://dx.doi.org/10.1097/MD.0000000000014382 |
Ejemplares similares
-
Spore powder of Ganoderma lucidum for the treatment of Alzheimer disease: A pilot study
por: Wang, Guo-hui, et al.
Publicado: (2018) -
A retrospective study of Ganoderma Lucidum Spore Powder for patients with epilepsy
por: Wang, Guo-hui, et al.
Publicado: (2018) -
Effects of spore powder of ganoderma lucidum on CaSR and apoptosis-related proteins in hippocampus tissue of epilepsy following dementia: A protocol of systematic review
por: Qin, Li-hong, et al.
Publicado: (2020) -
Triterpenoids from the spores of Ganoderma lucidum
por: Ma, Bingji, et al.
Publicado: (2011) -
Synthesis and Evaluation of Herbal Chitosan from Ganoderma Lucidum Spore Powder for Biomedical Applications
por: Zhu, Li-Fang, et al.
Publicado: (2018)